Medical Services Advisory Committee (MSAC) Applications
Key Objective
External evaluators for MSAC, in collaboration with ASERNIP-S (Australian Safety and Efficacy Register of New Interventional Procedures – Surgical)
The role of MSAC is to provide recommendations to the Australian Minister for Health and Ageing regarding the evidence relating to the safety, effectiveness and cost-effectiveness of health technologies and medical procedures. The recommendations of MSAC are used by the Australian federal government to decide whether public funding via MBS should be granted.
In 2007, ASERNIP-S and CHERE entered a formalised Memorandum of Understanding, outlining a collaborative approach to undertaking health technology assessments for MSAC. ASERNIP-S and CHERE have been working in collaboration for over 12 months, and this experience has allowed streamlined and cohesive approaches to economic assessment to be developed. Over the past year, we have produced a total of six reviews together for MSAC in what we believe is a successful and positive collaboration.
MSAC Applications since 2007-(in collaboration with ASERNIP-S)
- Application 1033 Autologous chondrocyte implantation (protocol)
- Application 1106 Endoscopic argon plasma coagulation therapy (to be presented to the MSAC executive)
- Application 1109 Deep brain stimulation for dystonia and essential tremor (current)
- Application 1113 Endovenous laser treatment for varicose veins (to be presented to the MSAC executive)
- Application 1115 Sacral nerve stimulation for urinary incontinence (current)
- Application 1123 Computer-aided total knee arthroplasty (current)
- Application 1129 Second Generation Contrast Agents for Use in Patients with Suboptimal Echocardiograms (complete)
- Application 1137 Middle ear implant for sensorineural, conductive and mixed hearing losses (under assessment)
- Application 1140 Matrix-induced Autologous Chondrocyte Implantation (MACI) and Autologous Chondrocyte Implantation (ACI) (current)
- Application 1143 Radiofrequency Ablation in Barrett's Oesophagus with Dysplasia (current)
- Application 1090.1 Review of MSAC Assessment 1090 - Artificial Intervertebral Disc Replacement (current)
- Application 1054.1 Review of MSAC Assessment 1054 - Hyperbaric Oxygen Treatment (HBOT) of two indications, late soft tissue radiation injury and radio necrosis and hypoxic problem wounds in non-diabetic patients (current)
Funding source
Australian Department of Health and Ageing
CHERE staff
Stephen Goodall, Richard Norman, Paula Cronin, Braedon Donald, Jody Church, Bonny Parkinson, Marion Haas
